Erratum

Source: Current Drug Targets, Volume 7, Number 12, December 2006 , pp. 1729-1729(1)

Publisher: Bentham Science Publishers

Buy & download fulltext article:

Price: $63.10 plus tax (Refund Policy)

Abstract:

Due to an overlook the names of some co-authors of the article “Cancer Cell Permeability-Glycoprotein as a Target of MDR Reverters: Possible Role of Novel Dihydropyridine Derivatives“, published in the journal Current Drug Targets, Volume 7, issue 8, August 2006, were missed in the article. The complete list of authors is as follows: F. Fusi, S. Saponara, M. Valoti, S. Dragoni, and P.D'Elia, T. Sgaragli, D. Alderighi, M. Kawase, A. Shah, N. Motohashi and G. Sgaragli.

Also Fig. (1) (page No. 950) and Fig. (2) (957) of the article were incorrectly printed .The correct figures are given below.

Document Type: Research article

DOI: http://dx.doi.org/10.2174/138945006779025464

Publication date: 2006-12-01

More about this publication?

Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will be devoted to a single timely topic, with series of in-depth reviews, written by leaders in the field, covering a range of current topics on drug targets. These issues will be organized and led by a guest editor who is a recognized expert in the overall topic. As the discovery, identification, characterisation and validation of novel human drug targets for drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.